BUY CJC-1295 | 4mg

Variants and Technical Specifications

• • • CJC-1295 with DAC (Drug Affinity Complex): Includes a chemical group that binds to albumin, CJC-1295 | 4mg extending its half-life to 6–8 days. This allows for infrequent dosing (typically 1–2 times per week) and provides a steady, sustained elevation of growth hormone.
    • CJC-1295 No DAC (Modified GRF 1-29): A short-acting version with a half-life of only 30 minutes to 2 hours. It is often administered 1–3 times daily to mimic the body’s natural pulsatile GH release, frequently before bedtime. 

Primary Research Benefits (2026)

• • Body Composition: Promotes lean muscle mass development and increases fat metabolism (lipolysis), particularly visceral fat.
    • Recovery and Sleep: Enhances tissue repair, joint health, and deep (slow-wave) sleep CJC-1295 .
    • Anti-Aging: Improves skin elasticity, hair quality, and bone density.
    • Synergy: Often “stacked” with GHRPs like Ipamorelin to maximize growth hormone pulses through two different receptor families. 

    Safety and Regulatory Status

    • Side Effects: Common reactions include injection site redness, head rushing/flushing, mild water retention, and tingling in extremities.
    • FDA Status: In 2026, CJC-1295 is not FDA-approved for human use. It has been placed on the FDA’s “Category 2” list due to safety concerns, including potential immunogenicity (harmful immune responses) and cardiovascular risks like increased heart rate.
    • WADA Status: It is a prohibited substance at all times in competitive sports under the World Anti-Doping Agency (WADA). 

    Handling and Storage

    • Reconstitution: Must be dissolved using Bacteriostatic Water 
    • Storage: The reconstituted solution is highly fragile and must be stored in a refrigerator at 2°C to 8°C to maintain potency.